The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
DUOLINGO INC CL A COM 26603R106   62,791,360 440,363 SH   SOLE   440,363 0 0
NEUBASE THERAPEUTICS INC. COM 64132K102   173,791 939,412 SH   SOLE   939,412 0 0
PREDICTIVE ONCOLOGY INC. COM NEW 74039M200   67,736 207,144 SH   SOLE   207,144 0 0
VERA THERAPEUTICS INC. CL A 92337R101   124,626 16,060 SH   SOLE   16,060 0 0
INNSUITES HOSPITALITY TRUST SH BEN INT 457919108   13,700 10,000 SH   SOLE   10,000 0 0
iShares Inc CORE MSCI EMKT 46434G103   86,452,318 1,771,927 SH   SOLE   1,771,927 0 0